Skip to content
Cleave Therapeutics Logo Cleave Therapeutics Logo
  • Home
  • About
    • Leadership Team
    • Board of Directors
    • Investors
  • Pipeline
  • Science
  • Newsroom
  • Contact
archivesjadvargas2022-04-11T12:59:05-07:00
Cleave Selected Press Releases Archive
<<< Back to Newsroom

Year

Press Release

2016 Cleave Biosciences Raises $37 Million Series B Financing
2015 Cleave Biosciences Granted Key U.S. Patent Covering CB-5083
Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma
2014 Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma
Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Advanced Solid Tumors
2013 Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
2011 Cleave Biosciences Raises Additional $2 Million in Series A Financing
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
© Copyright 2019 -    |   ALL RIGHTS RESERVED
Page load link
Go to Top